Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
Trials, Volume 12, Issue 1, 2011, Pages 67-67.
treatmentrisk assessmentconfidence intervalrisk factorsvirologyMore(11+)
Background Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compared to men but have limited options to reduce their HIV risk. Microbicides could fill an important HIV prevention gap for sexually active women who are unable to successfully negotiate mutual monogamy or condom use. Purpose This ...More
Full Text (Upload PDF)